Catalyst Wire Dossier Catalyst Wire Dossier

Zanubrutinib

zanubrutinib · BeiGene
Drug timelines are a Plus or Pro feature.

101 regulatory and trial events tracked for Zanubrutinib, covering 2020-05-13 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy [Phase 2, Phase 3]

See pricing